COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Missouri patients with a documented clinical need may be eligible for compounded tirzepatide.
Missouri’s healthcare centers in St. Louis and Kansas City provide strong access, but rural areas of the state have fewer local pharmacy options. Compounding Finder helps Missouri residents compare licensed pharmacies.
Yes. The Missouri Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.